starting retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Starting dose of retatrutide: the

If you are comparing the most common reactions people report, the article on common GLP-1 side effects is a helpful companion read

Clinical trial data from the SURMOUNT program provide the most robust evidence for expected outcomes

GLP-1-Rezeptor-Agonisten (kurz GLP-1-RA) bieten zwar einen nachweislichen Schutz vor Herzinfarkten, doch ihre Anwendung geht mit einem signifikanten Anstieg von Magen-Darm-Problemen einher

Youll receive a personalized care plan that includes lab testing, energy-boosting nutrition support, customized GLP-1 dosing schedules, and weekly follow-ups

France: The EUs Reimbursement Pioneer Across the Channel, a landmark policy decision has redrawn Europes GLP-1 landscape